Abbott Laboratories (ABT) Net Margin (2009 - 2026)

Abbott Laboratories has disclosed Net Margin across 18 years of filings, most recently posting 7.37% for Q2 2026.

• In Q2 2026, Net Margin fell 860.0% year-over-year to 7.37%; the TTM figure through Jun 2026 stood at 11.65% (down 2078.0% YoY), while the FY2025 annual figure was 14.72%, down 1723.0% from the prior year.
• Net Margin came in at 7.37% for Q2 2026 at Abbott Laboratories, down from 9.65% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 84.1% in Q4 2024 to a low of 7.37% in Q2 2026.
• Average Net Margin over 5 years is 17.76%, with a median of 13.97% recorded in 2022.
• Year-over-year, Net Margin surged 6853 bps in 2024 and plunged 6860 bps in 2025.
• Over 5 years, Net Margin stood at 10.24% in 2022, then jumped by 52 bps to 15.56% in 2023, then surged by 440 bps to 84.1% in 2024, then tumbled by 82 bps to 15.5% in 2025, then plunged by 52 bps to 7.37% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 7.37% in Q2 2026, 9.65% in Q1 2026, and 15.5% in Q4 2025.